Scientists are using new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24 million people globally.
Under a new grant from the National Cancer Institute, Advanced Cell Diagnostics will partner with the Cleveland Clinic to develop an ultrasensitive diagnostic test for B-cell lymphoma.Read More
A new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.Read More
A new study shows the MultiOmyx profile could improve disease assessment for both diseases using multiplex proteins.Read More
Ultra-sensitive detection of minimal residual disease now available to more people with blood cancers.Read More
Assay can aid physicians in better risk stratification and treatment of patients with diffuse large B-cell lymphoma.Read More
The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.Read More